Regeneron Pharmaceuticals, Inc. (REGN)
781.49
-11.77
(-1.48%)
USD |
NASDAQ |
Sep 11, 16:00
781.00
-0.49
(-0.06%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price : 781.49 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 800.00 | 800.22 | 780.81 | 781.49 | 443987.0 |
| Sep 10, 2026 | 794.36 | 806.14 | 792.00 | 793.26 | 526911.0 |
| Sep 09, 2026 | 803.83 | 808.63 | 796.72 | 807.65 | 621458.0 |
| Sep 08, 2026 | 814.36 | 821.17 | 799.42 | 810.31 | 556537.0 |
| Sep 04, 2026 | 840.06 | 841.54 | 825.83 | 827.72 | 561170.0 |
| Sep 03, 2026 | 858.18 | 859.34 | 837.63 | 843.47 | 496255.0 |
| Sep 02, 2026 | 826.24 | 854.49 | 825.77 | 852.03 | 749453.0 |
| Sep 01, 2026 | 808.86 | 824.63 | 804.32 | 823.82 | 682806.0 |
| Aug 31, 2026 | 782.44 | 802.78 | 779.08 | 799.08 | 894268.0 |
| Aug 28, 2026 | 809.40 | 809.40 | 789.08 | 794.19 | 488305.0 |
| Aug 27, 2026 | 806.18 | 817.62 | 804.27 | 807.71 | 766990.0 |
| Aug 26, 2026 | 827.78 | 831.67 | 814.70 | 814.79 | 585370.0 |
| Aug 25, 2026 | 829.22 | 839.94 | 823.44 | 833.56 | 505425.0 |
| Aug 24, 2026 | 834.51 | 834.70 | 823.40 | 828.50 | 672013.0 |
| Aug 21, 2026 | 835.74 | 847.00 | 826.64 | 834.04 | 786921.0 |
| Aug 20, 2026 | 831.70 | 840.82 | 826.05 | 826.64 | 596475.0 |
| Aug 19, 2026 | 817.17 | 844.92 | 815.38 | 840.84 | 750446.0 |
| Aug 18, 2026 | 814.00 | 821.02 | 805.93 | 810.24 | 779073.0 |
| Aug 17, 2026 | 801.76 | 813.18 | 795.73 | 805.93 | 541306.0 |
| Aug 14, 2026 | 802.35 | 806.54 | 792.57 | 803.48 | 425600.0 |
| Aug 13, 2026 | 802.21 | 815.80 | 794.49 | 805.97 | 709747.0 |
| Aug 12, 2026 | 790.55 | 801.36 | 784.61 | 797.99 | 575164.0 |
| Aug 11, 2026 | 808.80 | 813.63 | 796.66 | 797.00 | 939190.0 |
| Aug 10, 2026 | 781.72 | 809.09 | 775.83 | 808.05 | 1.214M |
| Aug 07, 2026 | 774.47 | 785.99 | 767.17 | 784.36 | 837598.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| AbbVie, Inc. | 257.12 |
| Gilead Sciences, Inc. | 143.72 |
| Amgen, Inc. | 377.35 |
| Biogen, Inc. | 217.15 |
Price Related Metrics
| PE Ratio | 19.31 |
| PS Ratio | 5.388 |
| PEG Ratio | 9.885 |
| Price to Book Value | 2.548 |
| Price to Free Cash Flow | 23.41 |
| Earnings Yield | 5.18% |
| Market Cap | 80.81B |
| PEGY Ratio | 7.957 |
| Operating PE Ratio | 20.05 |
| Normalized PE Ratio | 18.22 |